Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

TXG – 10x Genomics, Inc.

10x Genomics, Inc.
TXG
$13.08
Name : 10x Genomics, Inc.
Sector : Healthcare
Industry: Health Information Services
Mark. Cap: $1,609,977,984.00
EPSttm : -1.3
finviz dynamic chart for TXG
10x Genomics, Inc.
$13.08
2.75%
$0.37

Float Short %

13.48

Margin Of Safety %

-33

Put/Call OI Ratio

0.23

EPS Next Q Diff

0.35

EPS Last/This Y

1.44

EPS This/Next Y

0.05

Price

13.08

Target Price

13.43

Analyst Recom

2.32

Performance Q

61.48

Relative Volume

0.69

Beta

2.03

Ticker: TXG




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04TXG13.060.320.0211346
2025-07-07TXG11.930.320.0311340
2025-07-08TXG12.250.300.0411864
2025-07-09TXG12.090.300.0511925
2025-07-10TXG12.630.300.0111954
2025-07-11TXG12.80.240.1214521
2025-07-14TXG12.480.240.0714486
2025-07-15TXG12.220.230.0915079
2025-07-16TXG12.360.250.0314182
2025-07-17TXG12.450.250.0214188
2025-07-18TXG12.150.240.1114253
2025-07-21TXG11.580.320.1011077
2025-07-22TXG12.990.320.0411106
2025-07-23TXG13.630.230.0313962
2025-07-24TXG13.740.230.0614168
2025-07-25TXG14.110.220.0114214
2025-07-28TXG14.650.230.1314229
2025-07-29TXG140.230.2414242
2025-07-30TXG13.920.230.1714245
2025-07-31TXG13.450.230.3314128
2025-08-01TXG13.090.230.2314170
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04TXG13.01-1700.0-10.9-0.08
2025-07-07TXG11.93-1700.06.5-0.08
2025-07-08TXG12.25-1700.0-16.9-0.08
2025-07-09TXG12.10-1700.0-8.4-0.08
2025-07-10TXG12.62-1700.0-20.1-0.08
2025-07-11TXG12.80-1700.0-23.3-0.08
2025-07-14TXG12.47-1700.0-5.6-0.08
2025-07-15TXG12.22-1700.0-6.8-0.08
2025-07-16TXG12.36-1700.0-13.4-0.08
2025-07-17TXG12.45-1700.0-12.4-0.08
2025-07-18TXG12.15-1700.0-6.0-0.08
2025-07-21TXG11.52-1700.0-0.1-0.08
2025-07-22TXG12.99-1700.0-38.2-0.08
2025-07-23TXG13.62-1700.0-21.2-0.08
2025-07-24TXG13.73-1700.0-12.7-0.08
2025-07-25TXG14.11-1700.0-16.7-0.08
2025-07-28TXG14.68-1700.0-19.2-0.08
2025-07-29TXG14.00-1700.0-2.1-0.08
2025-07-30TXG13.91-1700.0-9.6-0.08
2025-07-31TXG13.45-1700.0-4.2-0.08
2025-08-01TXG13.08-1700.0-5.3-0.08
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04TXG0.014.6812.72
2025-07-07TXG0.014.8912.72
2025-07-08TXG0.014.8912.72
2025-07-09TXG0.014.8912.72
2025-07-10TXG0.014.8912.72
2025-07-11TXG0.014.8914.02
2025-07-14TXG0.014.9214.02
2025-07-15TXG0.014.9214.02
2025-07-16TXG0.014.9214.02
2025-07-17TXG0.014.9214.02
2025-07-18TXG0.014.9214.02
2025-07-21TXG0.015.0414.02
2025-07-22TXG0.015.0414.02
2025-07-23TXG0.015.0414.02
2025-07-24TXG0.015.0414.02
2025-07-25TXG0.015.0413.50
2025-07-28TXG0.016.9213.48
2025-07-29TXG0.016.9213.48
2025-07-30TXG0.016.9213.48
2025-07-31TXG0.016.9213.48
2025-08-01TXG0.016.9213.48
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.36

Avg. EPS Est. Current Quarter

-0.08

Avg. EPS Est. Next Quarter

-0.01

Insider Transactions

0.01

Institutional Transactions

6.92

Beta

2.03

Average Sales Estimate Current Quarter

139

Average Sales Estimate Next Quarter

144

Fair Value

8.74

Quality Score

44

Growth Score

46

Sentiment Score

42

Actual DrawDown %

93.7

Max Drawdown 5-Year %

-96.5

Target Price

13.43

P/E

Forward P/E

PEG

P/S

2.61

P/B

2.28

P/Free Cash Flow

36

EPS

-1.3

Average EPS Est. Cur. Y​

-0.08

EPS Next Y. (Est.)

-0.03

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-25.14

Relative Volume

0.69

Return on Equity vs Sector %

-46

Return on Equity vs Industry %

-37.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-5.3
10x Genomics, Inc.
Sector: Healthcare
Industry: Health Information Services
Employees: 1306
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
stock quote shares TXG – 10x Genomics, Inc. Stock Price stock today
news today TXG – 10x Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TXG – 10x Genomics, Inc. yahoo finance google finance
stock history TXG – 10x Genomics, Inc. invest stock market
stock prices TXG premarket after hours
ticker TXG fair value insiders trading